• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 17 of 100
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.
Retail
Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By Niclas Rolander and BloombergMarch 5, 2024
The Mark Cuban Cost Plus Drug Company will begin manufacturing its own medications in Dallas this week, cofounder and CEO Dr. Alex Oshmyansky announced Monday, March 4, 2024.
Health
Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
By Lindsey LeakeMarch 4, 2024
First over-the-counter birth control pill in U.S. begins shipping to stores
Health
First over-the-counter birth control pill in U.S. begins shipping to stores
By Matthew Perrone and The Associated PressMarch 4, 2024
Stock traders from various companies work in five circular and one semi-circular trading floor at the Frankfurt Stock Exchange.
Finance
Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy
By Ryan HoggMarch 3, 2024
BOXES OF WEGOVY DRUGS
Lifestyle
Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
By Prarthana PrakashFebruary 27, 2024
People sit and enjoy drinks in the sunshine at Nyhavn, a waterfront, canal and entertainment district in Copenhagen, Denmark
Newsletters
Denmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy
By Peter Vanham and Nicholas GordonFebruary 27, 2024
Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver
Commentary
Sanofi CEO: AI promises a great era of drug discovery that could fundamentally change medicine–but only if we allow it to deliver
By Paul HudsonFebruary 19, 2024
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers
Health
Patients see first savings from Biden’s drug price push, as Pharma lines up its lawyers
By Arthur Allen and KFF Health NewsFebruary 16, 2024
Jill Feldman, 54, poses for a photo at her home in Deerfield, Ill., on Jan. 19. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by blocking a signal that tells cancer cells to grow.
Health
As cancer treatment advances, advocates push back against ‘maximum tolerated dose,’ citing patient suffering
By Carla K. Johnson and The Associated PressFebruary 6, 2024
Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism.
Health
Experimental once-a-month weight loss injectable shows lasting results in early study
By Madison Muller and BloombergFebruary 5, 2024
U.S. drug price negotiations are underway. Here’s what that will mean for you—eventually
Finance
U.S. drug price negotiations are underway. Here’s what that will mean for you—eventually
By Chris MorrisFebruary 2, 2024
The last time there was this much hype over a new drug was for Viagra, which was approved in 1998. Yet hurdles remain, when it comes to the ability of patients to access weight loss and anti-diabetes injectables like Zepbound and Wegovy: These drugs cost a lot, insurance coverage is spotty, and patients may need to take them indefinitely to avoid regaining weight.
Health
Weight-loss injectables like Zepbound are making as big of a splash as Viagra, if not bigger. What you need to know about the ‘miracle drugs’
By Emma Court, Madison Muller and BloombergJanuary 31, 2024
‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’, arguing they keep old drugs too pricey
Politics
‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’, arguing they keep old drugs too pricey
By Elisabeth Rosenthal and KFF Health NewsJanuary 31, 2024
Big Pharma's favorite lab monkey, the long-tailed macaque.
Magazine
Big Pharma’s great lab monkey shortage: A crackdown on smuggling is causing chaos in America’s vital drug development pipeline
By Erika FryJanuary 27, 2024
A long-tailed macaque being held by lab employees.
Features
Why Big Pharma can’t quit the lab monkey business
By Erika FryJanuary 27, 2024
1...
  • 15
  • 16
  • 17
  • 18
  • 19
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.